BIONYSE United States
Market cap
$9.424 B
$352.47 +2.93%
Close of 7 Aug 2026
Revenue
$2.58B
#1003 by revenue
Earnings
$759.9M
#476 by earnings
Shares outstanding
—
Latest filing cover page
P/E ratio
12.4
Cap ÷ net income
Other share classes
Bio-Rad Laboratories lists more than one class of stock. Company figures above cover all classes combined.
Where these numbers come from
Share counts and financials for Bio-Rad Laboratories are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.